A predictable ligand regulated expression strategy for stably integrated transgenes in mammalian cells in culture

被引:38
作者
Anastassiadis, K
Kim, J
Daigle, N
Prengel, R
Schöler, HR
Stewart, AF
机构
[1] Tech Univ Dresden, BIOTEC, Max Planck Inst Mol Zellbiol & Genet, MPI CBG, D-01307 Dresden, Germany
[2] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany
[3] EMBL, Gene Express Program, D-69117 Heidelberg, Germany
[4] Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, New Bolton Ctr, Kennett Sq, PA 19348 USA
关键词
codon improved reverse tetracycline repressor fused to virion protein 16 activation domain (rtTA); rtTA-ligand binding domain transactivator; fusions; insulators;
D O I
10.1016/S0378-1119(02)00979-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Several strategies for regulated stable transgene expression in mammalian cells have been described. These strategies have different strengths and weaknesses, however they all share a common problem, namely predictability in application. Here we address this problem using the leading strategy for ligand inducible transgene expression, the tetracycline repressor system. Initially, we found the best stable clone out of 48 examined showed only 6-fold inducibility. Hence we looked for additions and modifications that improve the chances of a successful outcome. We document three important aspects; first, use of a mammalian codon-optimized tetracycline repressor gene; second, addition of a steroid hormone receptor ligand binding domain to the tetracycline repressor-virion protein 16 fusion protein activator; third, flanking the tet-operator/transgene cassette with insulator elements from the chicken beta-globin locus. By inclusion of these three design features, 18/18 clones showed low basal and highly inducible (>50 X) expression. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:159 / 172
页数:14
相关论文
共 26 条
[1]   Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances [J].
Baron, U ;
Bujard, H .
APPLICATIONS OF CHIMERIC GENES AND HYBRID PROTEINS PT B: CELL BIOLOGY AND PHYSIOLOGY, 2000, 327 :401-421
[2]   Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential [J].
Baron, U ;
Gossen, M ;
Bujard, H .
NUCLEIC ACIDS RESEARCH, 1997, 25 (14) :2723-2729
[3]   Transcriptional activator TGV mediates dexamethasone-inducible and tetracycline-inactivatable gene expression [J].
Böhner, S ;
Lenk, I ;
Rieping, M ;
Herold, M ;
Gatz, C .
PLANT JOURNAL, 1999, 19 (01) :87-95
[4]   Evaluation of an autoregulatory tetracycline regulated system [J].
Gallia, GL ;
Khalili, K .
ONCOGENE, 1998, 16 (14) :1879-1884
[5]   NEGATIVE EFFECT OF THE TRANSCRIPTIONAL ACTIVATOR GAL4 [J].
GILL, G ;
PTASHNE, M .
NATURE, 1988, 334 (6184) :721-724
[6]   Use of the human EF-1α promoter for expression can significantly increase success in establishing stable cell lines with consistent expression:: a study using the tetracycline-inducible system in human cancer cells [J].
Gopalkrishnan, RV ;
Christiansen, KA ;
Goldstein, NI ;
DePinho, RA ;
Fisher, PB .
NUCLEIC ACIDS RESEARCH, 1999, 27 (24) :4775-4782
[7]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[8]   TRANSCRIPTIONAL ACTIVATION BY TETRACYCLINES IN MAMMALIAN-CELLS [J].
GOSSEN, M ;
FREUNDLIEB, S ;
BENDER, G ;
MULLER, G ;
HILLEN, W ;
BUJARD, H .
SCIENCE, 1995, 268 (5218) :1766-1769
[9]  
Holzenberger M, 2000, GENESIS, V26, P157, DOI 10.1002/(SICI)1526-968X(200002)26:2<157::AID-GENE19>3.0.CO
[10]  
2-R